Co-hosting with the AGING Initiative, the goal of this webinar is to share impacts of implementation work through what the NIA prioritizes and a success story from an early mid-level researcher, as well as to provide information on identifying funding sources.

Wednesday, January 27, 2021
3:00 - 4:00 pm EST

Presenters:

• Marcel Salive, MD, MPH
  Division of Geriatrics and Clinical Gerontology National Institute of Aging
• Andrea Gilmore-Bykovskyi, PhD, RN
  Assistant Professor School of Nursing University of Wisconsin-Madison

Click "Visit Link" below to view the webinar video recording.

• Learn the Do’s and Don’ts of Project Management
• Identify Best Practices for Team Building
• Understand How to Create a Roadmap
• Obtain Tips on Building Infrastructure: Study Documents
• Recognize Common Data Collection Mistakes
• Learn What to Concentrate on to Monitor Progress
• Learn How to Build a Budget and Leverage Resources

The US Deprescribing Research Network (USDeN) is a community of people united by a shared interest in improving research on deprescribing for older adults. Funded by the National Institute on Aging, USDeN offers pilot grants, investigator development and education, an annual meeting, support for junior investigators, assistance with stakeholder engagement, resources for deprescribing research, and more including opportunities for collaboration and building community. Please visit their website at https://deprescribingresearch.org/ and register for their kickoff webinar on December 3, 2019 to learn more.

The Claude D Pepper Older Americans Independence Centers Coordinating Center is pleased to announce its first webinar! The goal of this webinar is to provide insights for writing a K grant application so as to not only promote its success, but also lay a strong foundation for development of a successful subsequent R-grant project.

The webinar will feature presentations by Jennifer Lai, MD from the University of California, San Francisco and Dorry Segev, MD PhD of Johns Hopkins University.

Click the associated link to view the Webinar recording (no password required).

UT Health San Antonio researchers, collaborating with the Mayo Clinic and the Wake Forest School of Medicine, are the first to publish results on the treatment of a deadly age-related disease in human patients with drugs called senolytics. The findings were posted Jan. 4 by the journal EBioMedicine, which is published by The Lancet.

The problems associated with an aging society transcend the boundaries of any specific discipline and play out across multiple biologic and societal domains ranging from individual cells, to organs and organ systems, to persons, to communities, to national and world economies. The six National Institute on Aging (NIA) Center programs address important topics in aging but typically from a specific disciplinary perspective.

The objective of the Research Centers Collaborative Network (RCCN) is to initiate new cross-disciplinary collaborative networks that bring together key thought leaders from each of the six NIA center programs to align approaches across programs that will uncover synergies and insights that lead to novel collaborations.

Age is the strongest risk factor for physical disability and Alzheimers disease (AD) and related dementias. As such, other aging-related risk factors are also shared by these two health conditions. However, clinical geriatrics and gerontology research has included cognition and depression in models of physical disability, with less attention to the pathophysiology of neurodegenerative disease. Similarly, AD research generally incorporates limited, if any, measures of physical function and mobility, and therefore often fails to consider the relevance of functional limitations in neurodegeneration.

PREPARE is a step-by-step program with video stories to help you have a voice in YOUR medical care, talk with your doctors, and give your family and friends peace of mind.

Metrnl secretion is reduced in injured aged muscle and is a critical component to the rejuvenating potential of “youthful” circulation. Metrnl therapy in aged muscle enhances regenerative capacity.

The New York Times article on Frailty and Surgical decision making featuring interviews with Johns Hopkins and UCSF OAIC personnel.

Agonistic angiotensin II type 1 receptor autoantibodies (AT1RaAbs) have not been associated with functional measures or risk for adverse health outcomes. AT1RaAbs could be used to stratify patient risk and to identify patients who can benefit from angiotensin receptor blocker treatment.

Online Gerontology Graduate Program - Americans are living longer than ever, and life expectancy is currently at a record high. More than 10,000 baby boomers turn 65 every day, and according to the Eldercare Workforce Alliance, the United States is ill-prepared to meet current and future workforce needs for its aging adult population.

The 6th Vital Sign is a global research study that uses Apple’s ResearchKit to measure a vital sign. Vital signs, like blood pressure or temperature, are measurements used by doctors and nurses to see how healthy a person is.

Chronological age, Biological age and why it matters.

The problem: ICU clinicians and researchers have no way to identify which patients are at greatest risk of functional decline after an ICU stay
Our niche: Our prior work has demonstrated the importance of pre-ICU factors in determining post-ICU outcomes
Study objective: To identify predictors of functional decline among older ICU survivors and develop a prediction tool for post-ICU disability